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The use of antigen tests for the diagnosis of COVID-19 in Italy has
risen sharply in autumn 2020. Although, Italian regions like Alto Adige,
Veneto, Toscana, Lazio, Piemonte and Marche did a large use of these
tests for screening and surveillance purposes or for implementing diagnosis
protocols, in addition to molecular tests, they were not reported in the
statistics in the last months of 2020. As a consequence of this situation the
test positivity rate (TPR) index, defined as the number of new positive
cases divided by the number of tests, has lost in accuracy. Only in the
recent days, starting from the 15th of January 2021, antigen tests have
become part of the statistics for all the Italian regions. Despite the lack of
data, we have noticed that TPR has a strong correlation with the number
of patients admitted in hospitals, and that TPR peaks in general precede
the peaks of hospitalized people which occur on average about 15 days
later.
In this paper, we have deepened this intuition, analysing the TPR
course and its relationship with the number of hospitalized people. To
conduct the study we have defined a novel version of the TPR index
which takes into account the number of tests done with respect to the
population (considering both molecular and antigen tests), the number
of infected individuals, and the number of patients healed. Successively,
starting from a limited set of data which were made available in November
2020, we have reconstructed the antigen tests time series of four Italian
regions, and we computed the TPR index for them.
The results show that TPR peaks precede peaks of hospitalized people
in both the first and the second phases of the pandemic in Italy, provided
that antigen tests are considered. Moreover, the TPR index trend, can
be used to deduct important information on the course of the epidemic,
and on the impact of COVID-19 in the health care system, which can be
monitored in advance.
Keywords: COVID-19, test positivity rate, antigen test, standardization
1
1 Introduction
In spite of the fact that antigen tests for the diagnosis of COVID-19 have been
extensively used in Italy since October 2020, they were not reported in a stan-
dardized form in the data provided by the Italian Protezione Civile Department
[17] in the last months of 2020. In some Italian regions like Piemonte, Lazio
and Marche antigen tests data were mixed with molecular tests, while for re-
gions like Veneto, Toscana and Alto Adige they were partially reported only as
additional text comments in the csv file, and for other regions the real situation
concerning their use was unknown.
The consequence of this lack of data is that, it was not possible to compute a
reliable test positivity rate (TPR) index in the last months of 2020, comparing
it in all the 21 regions of Italy.
This inconsistency in the provided data is only a minor drawback, indeed
TPR appears to be a powerful tool for monitoring the evolution of the epidemic
course that it was not possible to study accurately. Traditionally, TPR has been
used to estimate the incidence of diseases in the population, for example for
malaria disease [1]. For a similar purpose, it has been recently used to estimate
COVID-19 prevalence in the different states of US [10]. It is also recommended
by World Health Organization to test positivity proportion from sentinel sites
to establish levels of community transmission [11]. However, beyond these well
known applications, the large amount of data collected in the COVID-16 pan-
demic, would allow researcher to explore the use of TPR in different contexts,
that previously could not be addressed due to the lack of epidemiological data.
For example, we used the TPR combined with epidemiological data in the devel-
opment of a simulator for reproducing the outbreak process and estimating the
impact of the disease in the population at the end of June 2020[18]. The simu-
lator was able to forecast the number of infected people in Italy as confirmed by
the serological survey of the Italian Institute for Statistics (ISTAT) published
the 3rd of August 2020 [19]. More precisely, the number of case computed by
the simulator were in the ranges of the data reported by the ISTAT survey for
16 out of 21 regions, for the whole Italy, and the remaining regions were not far
away.
The simulator used the daily growth percentage of official cases to estimate
how unknown cases grow adding a variable part which depends on TPR and on
a factor K. If the number of asymptomatic cases increases like in the summer
K increases, vice-versa it decreases. The factor K is quite difficult to estimate,
whilst the TPR can be effectively computed. While tuning the simulator in the
second phase of the pandemic an interesting correlation has emerged: the peaks
of the daily TPR index were apparently related to the peaks of hospitalized
patients in some of the regions. We did an extensive analysis of this marker,
showing that peaks of patients in hospitals and intensive care units occurred on
average 16 and 12 days after the TPR peaks in the first phase of the pandemic,
and that this forecasting capability is preserved in the second phase if data on
antigen tests are used.
In this paper, the results of this research are presented. To conduct the
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study, we have defined an novel version of TPR index that can be computed
daily and takes into account the number of tests done considering both molecular
and antigen ones, the tests used for patients healed, and the number of infected
individuals with respect to the population. Quoting a recent report of the World
Health Organizzation: if the TPR is used in a general (non-sentinel) setting it
is heavily influenced by testing strategy and capacity [11]. As far as we know
the TPR has not yet being standardized for COVID-19, our proposal can be
considered one of the first attempts to achieve this goal. Although, the weekly
index computed in the ISS reports [14] is more accurate than the one we are
proposing, it is outdated, namely it estimates the positivity rate more than one-
week back with respect to when it is calculated. It cannot be computed daily
because many data have to be collected and carefully analysed to discard most
of the tests not used for diagnosis purpose.
In our opinion, the results presented in this study could have an enormous
importance for the monitoring of the pandemic. What we show is that, if ap-
propriately tuned and standardized the TPR index could become a tool able to
predict in advance the impact of the disease in the health care system, to analyse
the situation in different areas of the country, and promptly take appropriate
actions where this appears necessary.
We conclude the paper, by presenting a proposal for an extended version of
the TPR index to be used if data on antigen tests are made available in a correct
and more structured form, like it recently happened in Italy. This extended TPR
index provides a better integration of antigen tests with molecular tests data,
also including vaccinate people.
2 The test positivity rate index
Test positivity is one of the metrics commonly used to infer the level of trans-
mission of a disease in a population, it is one of the indexes that the Italian
institute for health ISS uses for monitoring the COVID-19 pandemic in Italian
regions [13, 14, 15].
We define here a novel version of this index, that can be computed daily.





where dayP and dayT are respectively the new positive cases of the day and
the number of tests, e.g. nasopharyngeal swab (NS), done in same day.
To address data bias, indeed data include several anomalies, we considered
the average value of dayP and dayT in the last µ days, where µ is the incubation
period. Using the percentage of positive tests administered over a given period
is a common technique to estimate this index [10]. For example, the World
Health Organization recommends to compute it from averaged values over a
two-week period [11].
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Another issue concerns modelling the number of tests done in a given day
that are used to diagnose the healed. These tests should not be considered in
the total amount of tests; we denote them with dayR.





The reasoning behind choosing the length of the incubation period for computing
the average values is related to the fact that the set of exposed individuals in a
given day will be emptied in about µ days, and in the meantime new exposed
are added. In other words, if the size of the exposed individuals increases the
number of infections detected in the next µ days will increase at the same pace.
Finally, a factor Φ is added to Θ to model the impact of the number of
tests on the remaining susceptible individuals, which are computed removing
the total infected cases I from the population N of a given region.
Φ =
N − I − dayTµ + dayRµ
N − I
(3)
This factor can be also extended to model persons who are vaccinated, removing
them like infected individuals. We will consider this issues in the last Section.
The new definition of TPR is the following:
ΘΦµ = Θµ ∗ Φ (4)
Needless to say, it would be possible to define more precise measures, however
this will make the collection of data more difficult. In our opinion our TPR
index is a reasonable compromise between what it can be actually collected and
effectively represented.
3 Correlation with hospitalized patients data
Considering the data provided by the Italian Protezione Civile Deparment [17],
we did a detailed analysis to study how the TPR index (equation 4) peaks are
related to the peaks of hospitalized data.
3.1 The first phase
We started from the first phase of the pandemic in February 2020, calculating
the TPR peaks for each region, and comparing them with hospitalized and
intensive unit patients peaks. Hospitalized data includes patients in intensive
care units. To address data bias, we discarded the first 7 days at the very
beginning of the curve1, and then we moved a few days ahead if the TPR is in
a descending phase, until it starts increasing again. Starting from this position,
we found the highest value of TPR in the first phase, and we computed the
1The day in which the first positive individual was detected in a given region
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Table 1: First phase of the pandemic: the first column shows the TPR peak
dates and values for all the Italian regions; the second column shows the peak
of hospitalized patients, their number and the distance in days from the TPR
peak; the third column does the same for patients in intensive units; and the
last two columns present the increment percentage of hospitalized patients at
the TPR peak to reach the maximum.
Region TPR peak Hosp days peak IU days peak Hosp UI
Date: rate Date:cases,days Date:cases,days inc% inc%
Abruzzo 21-03:24.36 03-04:(437, 13) 03-04:(76, 13) 47.6 42.11
Basilicata 18-03:17.76 13-04:(76, 26) 28-03:(19, 10) 85.53 89.47
AltoAdige 25-03:13.98 07-04:(389, 13) 08-04:(65, 14) 40.87 38.46
Calabria 16-03:11.33 03-04:(200, 18) 25-03:(23, 9) 78.5 69.57
Campania 18-03:25.32 05-04:(717, 18) 24-03:(181, 6) 78.94 86.74
Emilia-R. 06-03:41.61 02-04:(4310, 27) 05-04:(375, 30) 89.56 85.87
Friuli 19-03:39.17 29-03:(296, 10) 03-04:(61, 15) 44.93 52.46
Lazio 24-03:14.01 27-04:(1607, 34) 11-04:(203, 18) 47.67 53.69
Liguria 24-03:41.55 31-03:(1332, 7) 31-03:(179, 7) 28.68 17.88
Lombardia 20-03:60.78 04-04:(13328, 15) 03-04:(1381, 14) 34.09 23.97
Marche 17-03:56.85 29-03:(1168, 12) 31-03:(169, 14) 39.38 35.5
Molise 16-03:26.09 01-04:(40, 16) 27-03:(9, 11) 80.0 44.44
Piemonte 23-03:42.33 07-04:(3985, 15) 01-04:(453, 9) 36.34 24.28
Puglia 24-03:15.97 04-04:(780, 11) 05-04:(159, 12) 52.05 64.15
Sardegna 19-03:19.64 05-04:(151, 17) 08-04:(31, 20) 65.56 70.97
Sicilia 25-03:15.09 06-04:(637, 12) 25-03:(80, 0) 46.78 0.0
Toscana 18-03:21.8 03-04:(1437, 16) 01-04:(297, 14) 59.15 46.13
Trentino 16-03:53.96 07-04:(438, 22) 04-04:(81, 19) 79.0 76.54
Umbria 19-03:18.75 30-03:(220, 11) 03-04:(48, 15) 59.09 56.25
V.d’Aosta 31-03:62.33 10-04:(147, 10) 01-04:(27, 1) 20.41 3.7
Veneto 17-03:12.0 01-04:(2068, 15) 30-03:(356, 13) 65.23 51.97
distance in days with the hospitalized and intensive unit peaks. The results are
reported in Table 1.
The study shows that the peaks of hospitalized patients occur from about
10 to 18 days after the TPR peak for the majority of regions. The average
distance of hospitalized peaks is 16.1 days, and of intensive unit peaks is 12.57
days. The average increment for patients admitted in hospitals was 56.16%, and
the average increment for patients in intensive units was 49.25%.
To compute the TPR index, we first assumed an incubation period µ of 5
days [20] to average the data. Indeed, we have found that, if the number of
considered days deviates from the length of the incubation period, the average
difference between TPR peaks and hospitalized patients peaks decreases. Thus,
the forecasting capabilities of TPR deteriorates. Table 2 illustrates this result
comparing 4 days, 5 days, 6 days, 7 days and 14 days based averages, using the
basic version of the index (equation 4): choosing µ for computing average values
was correct. However, we observed that using 5 days only, a few peaks in some
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Figure 1: Emilia Romagna region: TPR index compared with hospitalized data.






























Figure 2: Trentino region: TPR index compared with hospitalized data.
regions still were caused by bias effects on data. So, we have preferred 6 days
to average the data, as a compromise to reduce the bias effects maintaining a
good forecasting ability. Anyhow, the COVID-19 incubation period ranges on
average between 5 and 6 days.
A critical point of the factor Φ (equation 3) is that it needs the number of
infected people to be computed, but real cases are actually many more then
those reported in official data, as pointed out in several studies, for example
[21, 12, 18]. This was confirmed for Italy by the Italian Statistical Institute
serological survey [19]. Given that the simulator we have developed [18] provides
a good approximation of unknown cases in the first phase of the Pandemic in
Italy, we repeated the study using the number of infected people computed
by the simulator for each day. The results show that there are no significant
differences and the average distance of peaks remain the same, thus the number
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Figure 3: Basilicata region: TPR index compared with hospitalized data.
Table 2: How different means over N days influence the TPR peak date: on
average the peak is pushed forward if the number of considered days deviates
from the incubation period.
Curve 4 days 5 days 6 days 7 days 14 days
Hosp 15.9 16.9 16.1 14.57 13.38
IU 12.38 13.8 12.57 11.05 9.86



































Figure 4: Lazio region: TPR index compared with hospitalized data.
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Figure 5: Lombardia region: the TPR index was still above 0 at the beginning
of June 2020.
of infected people reported in official data can be actually used for computing
the TPR index in the first phase of a pandemic.
Looking back to Table 1, we note that for some of the regions like, Basilicata,
Emilia Romagna, Lazio and Trentino the time to reach the peak is considerably
longer than the mean number of 16 days. Observing their graphs one can see
that all of them were characterized by an uncontrolled period where the TPR
remains high: four weeks for Emilia Romagna (Figure 1) and two weeks for
Trentino (Figure 2) where the TPR was about to 35%. For both these regions
the percentage increment to reach the peak of hospitalized and IU patients is
fairly high (more then 79%). Considering Basilicata (Figure 3) there where
one week where the TPR was about to 15%, and the increment of patients rate
more than 85%. On the contrary, considering the Lazio region (Figure 4), where
the TPR was about to 12%, the time to reach the peak was shorter and the
added percentage to hospitalized people not so great (about 47%). As a further
example of the first phase it is worth to report the diagram of region Lombardia
(Figure 5). Note that unlike other regions the TPR index at the beginning
of June 2020 was still significantly above 0. This is one of the motivations of
the high number of active unknown cases estimated by our simulator at the
beginning of June 2020 for the Lombardia region [18]. The diagrams of the
remaining 16 Italian regions are sketched in Figure 6 and 7.
3.2 The second phase
The second phase of the epidemic in Italy broke out in autumn. From the
perspective of diagnosis tools the second phase is characterized by the growing
use of antigen tests [16]. We repeated the study in the second phase (until the
5th of December 2020), starting from the 1st of October 2020 using equation 4
again. In this case the correction of initial bias was not necessary. The 5th of
8






































































































































































































































































Figure 6: TPR index compared with hospitalized data for regions in the south










































































































































































































































































Figure 7: TPR index compared with hospitalized data for regions in the north
and center of Italy.
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Table 3: Second phase of the pandemic until the 5th of December 2020: the first
column shows the TPR peak dates and values for all Italian regions; the second
column shows the peak of hospitalized patients, their number and the distance
in days from the TPR peak; the third column does the same for patients in
intensive units; and the last two columns present the increment percentage of
hospitalized patients at the TPR peak to reach the maximum.
Region TPR peak Hosp days peak IU days peak Hosp UI
Date: rate Date:cases, days date:cases, days inc% inc%
Abruzzo 14-11:17.11 30-11:(790, 16) 28-11:(77, 14) 23.54 23.38
Basilicata 11-11:14.93 04-12:(185, 23) 17-11:(30, 6) 17.84 36.67
AltoAdige 13-11:26.92 16-11:(530, 3) 14-11:(44, 1) 6.79 6.82
Calabria 23-11:17.26 23-11:(482, 0) 17-11:(53, -6) 0.0 11.32
Campania 07-11:20.16 23-11:(2532, 16) 03-11:(227, -4) 23.58 21.15
Emilia-R. 26-11:15.55 25-11:(3012, -1) 26-11:(258, 0) 2.49 0.0
Friuli 23-11:14.5 02-12:(710, 9) 01-12:(62, 8) 12.68 11.29
Lazio 18-11:10.93 27-11:(3762, 9) 03-12:(364, 15) 10.31 12.64
Liguria 07-11:20.91 14-11:(1510, 7) 25-11:(123, 18) 8.61 37.4
Lombardia 19-11:27.77 22-11:(9340, 3) 22-11:(949, 3) 1.43 3.58
Marche 14-11:20.22 29-11:(683, 15) 25-11:(94, 11) 18.3 21.28
Molise 21-11:13.96 26-11:(78, 5) 30-11:(14, 9) 23.08 35.71
Piemonte 11-11:25.54 20-11:(5618, 9) 24-11:(404, 13) 8.69 15.84
Puglia 05-12:19.31 01-12:(1911, -4) 04-12:(227, -1) 6.02 3.08
Sardegna 21-11:13.77 05-12:(674, 14) 25-11:(76, 4) 14.84 7.89
Sicilia 18-11:18.98 23-11:(1847, 5) 26-11:(253, 8) 4.28 5.14
Toscana 11-11:16.3 23-11:(2128, 12) 22-11:(298, 11) 11.94 17.45
Trentino 10-11:11.41 24-11:(478, 14) 05-12:(48, 25) 33.47 41.67
Umbria 09-11:16.68 23-11:(449, 14) 23-11:(78, 14) 5.57 17.95
V.d’Aosta 19-11:33.42 03-11:(183, -16) 11-11:(17, -8) 14.75 29.41
Veneto 05-12:28.91 28-11:(2963, -7) 30-11:(320, -5) 5.47 2.5
December was a good date for evaluating the TPR index because most of the
regions had already reached the peaks of hospitalized persons.
What we got is that the forecasting capabilities of TPR have deteriorated of
more than one half in the second phase, obtaining an average of 6.95 and 6.48
days ahead with respect to hospitalized and intensive units peaks respectively.
On the contrary the increment of hospitalized people was lower on average:
12.08% for patients admitted in hospitals people and 17.25% for patients in
intensive units. Table 3 shows the details for each region.
It seems that the TPR index has lost most its forecasting capabilities in the
second phase. One possible hypothesis is that the results of the first study have
been influenced by the lockdown strategy started the 9th of March 2020.
However, analysing the details of the single regions, it appears that for some
of them the TPR forecasting capabilities are preserved: Abruzzo, Basilicata,
Friuli, Marche, Toscana, Trentino, Umbria. Nevertheless, for many other a
strange effect leaps to the eye: the peaks hospitalized people precede the peak
11
of infections (TPR index), among them Veneto and Emilia Romagna. An expla-
nation of this phenomenon could be that in those regions infections are detected
much after, compared to when they occur. Is the pandemic not well controlled
in these regions? This is an obvious contradiction, indeed Veneto and Emilia
Romagna have probably among the best contact tracing systems in Italy, as il-
lustrated by the ISS weekly reports (see for example [14] and [15]). So a second
hypothesis seems to be more plausible: the computed TPR index does not work
properly in these cases, because antigen tests which are largely used in Veneto
and in Emilia Romagna are not included so far in the official data provided by
the Italian Protezione Civile web site [17]. The situation of Veneto is confirmed
by the ISS weekly report N.29 [13] and by the notes transmitted by the Veneto
region in November 2020 available in the csv (Comma Separated Values) file of
italian regions in the Protezione Civile web site [17], in which the antigen tests
numbers were included for a short period in the text notes only.
This point was controversial, for regions like Veneto, Toscana and Alto Adige
some data on antigen tests were available in the text notes of the csv file [17] in
November 2020, but unfortunately the transmission of antigen data was stopped
even in the text notes in December 2020. Thus, it was not possible for us to
study the last period of the second phase.
Despite this, we were able to collect the data on antigen tests for the above
three regions until the 5th of December, extracting them from the csv file notes,
when they were available, or searching them on the web and on the news. These
data were sufficient for us to evaluate the impact of antigen tests in the TPR
index.
In order to perform the new study a TPR index extended with antigen tests
should be defined properly.
4 Extending TPR with antigen tests data
First we define a basic method that would allow us to compute the TPR index if
only the total number of antigen tests done in each day is given. This is actually
the situation of data on antigen tests we have collected.
A problem concerning the representation of antigen tests information is that
in the considered period almost all the positive ones had to be confirmed by
molecular tests. Thus tests of positive cases individuated with antigen tests are
repeated two times, and should not be considered in the estimation of TPR. If
the number of positive antigen tests would be available, it should be subtracted
to the total number of tests to compute the TPR, but unfortunately this is not
the case of the data available in the last months of 2020. Additionally, there is a
further representation problem concerning repeated tests, because the molecular
tests that are needed to confirm the diagnosis could be done in the successive
days. We have solved this problem using average values on µ days for both
molecular and antigen tests, estimating an average number of repeated tests.
In spite of this problem, we can estimate the number Pr of repeated tests as
follows. Let PT and PA be the positivity percentage of molecular and antigen
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where dayA is the number of antigen tests and dayT the number of molecular
tests in a given day. If we assume that the positivity rates for antigen tests and
molecular tests are the same, e.g. PT=PA, we can estimate the number Pr of
repeated tests equalizing the two formulas. The number of repeated tests Pr





Given that in general PT>PA, see for example the results presented here [7], the
computed number of repeated tests Pr can be considered a reasonable upper
bound for the estimation. However, if more data will be made available to
estimate the difference between the two percentages PT=ψ*PA, a more accurate
definition of Pr would be possible:
Prψ =
dayAµ ∗ dayPµ
ψ ∗ dayTµ + dayAµ
(8)
In the following, we will use the upper bound defined in equation 7. The
TPR ΘAµ that include antigen tests is defined removing from the total number
of tests the repeated ones:
ΘAµ =
dayPµ ∗ 100
dayTµ + dayAµ − dayRµ − Pr
(9)
The factor Φ is extended removing antigen tests except duplicates.
ΦA =
N − I − dayTµ − dayAµ + dayRµ + Pr
N − I
(10)
Finally, the TPR index ΘAµ including antigen tests is defined as follows:
ΘAµ = Θ
A
µ ∗ ΦA (11)
4.1 The effect of antigen tests in the TPR index
Considering this extended version of the TPR index, we have analyzed the data
of Veneto, Alto Adige and Toscana up to the 5th of December 2020. When
available, we used the data that appeared in the csv file notes in the official web
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site [17], and we have completed them for each region adding an antigen tests
column as follows:
• Toscana: cumulative antigen tests data where available in the csv file
notes [17] from the 22th of October 2020, but for several days the notes
were missing. However, for the missing days it was possible for us to get
the exact numbers of antigen tests done from the news [25], indeed the
regione Toscana reports published daily. We double checked these data
with those available in the csv file notes, and we were able to reconstruct
the entire series until the 4th of January 2021.
• Veneto: cumulative antigen tests data where available in the csv file notes
[17] from the 11th of November 2020, in that day the total of 492456
was reported and the other cumulative values were successively added,
until the 2nd of December 2020, then disappeared. The values for the
successive days has been taken listening to press conferences of regine
Veneto. Cumulative values prior to the 10th of November were gradually
distributed until the 3rd of October 2020.
• Alto Adige: the daily antigen test data were available in the csv file notes
[17] since the 6th until the 20th of November 2020, meanwhile a screening
campaign has started, involving a large percentage of the population [22,
23]. However, the data of the screening were only partially integrated
with those in the official Web site. The screening web site [22] reported
the number of antigen tests done in each day and the number positive
tests, but only the positive tests were included in the Protezione Civile
csv file as notes2, not including them among the official positives. Thus,
for the period from 21th November to the 24th (the data in the Protezione
Civile are reported one day after with respect to the screening ones), we
merged screening data with those in the official web site, inserting antigen
tests in the new column, and adding the positive cases to official positives
until the 27th of November. For the successive days data on antigen tests
have been made available in the reports of the Provincia di Bolzano web
site [8]. In summary, we were able to rebuild the complete series for Alto
Adige integrating screening data.
The results of the study are presented in Table 4, we used equation 11 to
compute the TPR index. The table shows that the forecasting capabilities of the
TPR index have been restored for the analyzed regions. The average distance of
the TPR peaks from the hospitalised people peaks moves from 2 to 12.66 days
for these regions, and the average distance for all the Italian regions reaches 8.38
days. The average increment of hospitalize people for the 3 considered regions
increases to 22.66% and that of patients in intensive units moves to 20.65%.
Figures 8, 9 and 10 illustrate the sliding of the TPR curve using antigen tests
in the estimation in Veneto, Toscana and Alto Adige.
2The positivity to SARS-CoV-2 infection was followed by home isolation measures without
carrying out a confirmative PCR test [23]
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Table 4: This table presents the results of the study for the regions for which
antigen test data were available in November 2020, the organization of data is
the same of the previous Tables.
Region TPR peak Hosp days peak IU days peak Hosp UI
Date: rate Date:cases,days date:cases,days inc% inc%
AltoAdige 09-11:20.8 16-11:(530, 7) 14-11:(44, 5) 14.72 6.82
Toscana 04-11:14.81 23-11:(2128, 19) 22-11:(298, 18) 28.76 33.89
Veneto 16-11:9.47 28-11:(2963, 12) 30-11:(320, 14) 24.5 21.25











































Figure 8: Toscana region: TPR index sliding compared with hospitalized data.
The diagram in the bottom includes antigen tests in the estimation.
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Figure 9: Veneto region: TPR index sliding compared with hospitalized data.
The diagram in the bottom includes antigen tests in the estimation. The daily
data on antigen test before the 11th of November 2020 were not available, we
distributed the total number of tests reported for the 11th of November in the
previous days until the beginning of October.
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Figure 10: Alto Adige region: TPR index sliding compared with hospitalized
data. The diagram in the bottom includes antigen tests in the estimation. The
fast descent of the TPR index corresponds to the screening period from the 21th
to the 23th of November 2020.
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Veneto: TPR index using antigen tests
ISS yellow zone 06-11
Veneto yellow+ zone 12-11
Veneto orange zone 21-12
ISS orange zone 09-01
Christmas breakwater start 24-12













Figure 11: Veneto region: evolution of the TPR peaks and hospitalized peaks.
Considering that there are other regions, like Emilia Romagna that definitely
have the same problem concerning availability of antigen tests data, we can argue
that the TPR index maintains its forecasting capability in the second phase.
Hence, it would be a recommendable tool to be used for decision support in
these day, given that antigen tests data are now available.
5 Discussion
From the analysis of the course of the pandemic in the modelled regions several
interesting considerations emerge.
5.1 The evolution of Veneto and Toscana regions
The course of the epidemic in Veneto was different from that of most other
regions. Indeed the TPR index has not suddenly decreased after the peak of
the 16th of November 2020, and after a peak of hospitalized people the 28th
of November, the TPR index started to grow again slowly. A new TPR peak
occurred the 9th of December, surpassing the previous one. This is the peak
that was discovered later by ISS in the weekly report N. 31 of the 16th of
December 2020 [15], concerning period between the 7th and 13th of December.
Successively, 8 days later there was another peak of hospitalized people the
17th of December, but the growth rate of patients remained limited. In the last
period, there was another TPR peak the 29th of December (see Figure 11), and
after that another peak of hospitalized people the 4th of January. Once again,
the growth percentage of hospitalized patients was not high, and successively
the TPR began to fall steadily, and the number of patients in hospital started
to lower. Given the consistent reduction of the TPR index, the number of
patients will definitely decrease in the next few weeks, and this is effectively
what happened.
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Toscana: TPR index using antigen tests
ISS yellow zone 06-11
ISS red zone 15-11
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Figure 12: TOSCANA region: TPR index fall after the Christmass breakwater.
In summary, despite restrictions in Veneto were not so strong as those of
other regions, the strategy characterized by a large number of tests and thorough
tracking of contacts, is contending for the spread of the virus and prevented the
collapse of the health care system, without excessively penalising the economy.
The Toscana region is characterized by a more simple evolution of the TPR
index curve, after the peak TPR dropped quickly, while it has started to rise
gradually before Christmas, and the number of patients in hospitals has de-
creased more slowly, see Figure 12. Possibly, the different course of the epidemic
in Toscana and Veneto is related to the adopted measures, we address this issue
as the last point of this discussion.
5.2 The impact of antigen tests on the TPR index
Another important issue which has been raised by some scientists, concern anti-
gen tests sensitivity. Given that we assumed that positive antigen tests are in
general confirmed by molecular ones, false positives do not pose a significant
problem for the model.
Although, the false negatives percentages reported in the literature for novel
antigen tests are not high [3, 4, 5], some scientists still doubt about their sen-
sitivity in specific situations, for example with asymptomatic individuals [7],
albeit the presented results are about salivary tests [6] not NS. However, the
results of these studies strongly depend on the tests used, and actually there
are many different tests around, see for example [2, 26]. It is not our inten-
tion here to shed light on this dispute, anyway FDA still recommend that it
is not necessary to perform confirmatory molecular tests on individuals with
negative antigen test results, if they are obtained during routine screening or
surveillance [9], and they can actually be used for implementing cost effective
diagnostic testing strategies [24].
Therefore, we focus on answering the question: may antigen tests failures
19

















































Figure 13: Veneto region: How the TPR index changes if we reduce the weight
of antigent tests by 15% in the top or by 30% in the bottom. The trend and the
peaks remains at the same with respect to Figure 11, we can argue that claiming
that antigen tests caused the increase in infections is clearly unfounded.
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Figure 14: ALTOADIGE region: the effects of the November 2020 screening
campaign.
have a significant impact on the TPR index trend? In other words, assuming
that a significant percentage of antigen tests fail, will have an effect in the dates
in which the peaks occur? We cut down the number of antigen tests by 15% and
30% (a reasonable upper bound for failures), and we computed the TPR index
for the studied regions. What happened is that the TPR trend has remained
unchanged without altering the dates of the peaks in Table 4. For example,
figure 13 shows the TPR variations for Veneto, a small increment of the index
is observed, but the trend does not changes. Hence, there is no evidence that
unreliable antigen tests caused the increase of infections in Veneto.
5.3 The mass screening campaign of Alto Adige region
Considering the Alto Adige region, it is worth to report the effects of the mass
screening on the TPR index and on hospitalized people which is illustrated in
Figure 14. After the screening there were a considerable reduction of the TPR
index (the lowest value in all Italy) and of the number of patients in hospitals.
However, after one week the TPR index has begun to grow again. A factor that
may had an important effect on the results of the screening campaign was the
large number of exposed individuals. Indeed, if more than 3000 people were
detected as positive in 3 days only, there could be at least the same number of
people still incubating the virus, that was not possible to detect in the screening.
This issue is about the course of the disease, and it is not related to possible
antigen tests failures. Another observation concern the fact that the hospitalized
patients peak was only 7 days after the TPR peak, possibly this depends from
the fact that Alto Adige started to use antigen tests before the 6th of November,
but these tests were not reported in official data. This hypothesis is confirmed
by this study [7] which uses antigen tests, it was done in Alto Adige in the
summer. In the last week of December an additional information was added to
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the provincia of Bolzano reports: the number of positive antigen tests. When
they appeared, at the end of December, they were not included in the official
data as new positive cases. However, given that when the new information was
added (the 15th of January 2021), they were added to official positive cases, we
updated the dataset using the same logic. In other words, we added the number
of positive antigen tests reported by provincia of Bolzano to the number of new
positive cases.
5.4 Analysing Piemonte region
A further case that is worth to report concern the Piemonte region. In the
middle of the month of December there was an evident break in the molecular
tests series, when two hundred thousand tests were removed in one day, they
were the antigen tests done starting from the 22th of October. As a result
of this operation the TPR shot up through the roof, Figure 15 illustrates this
effect. Thanks to the data made available in the web site of the region Piemonte
health assessor [27], we were able to rebuilt the complete molecular tests series
removing antigen tests (Figure 15 in the middle), and successively we introduced
antigen tests as a separate series. With this dataset we were able to compute
the TPR index for Piemonte. The results are that the relationship between the
TPR index and hospitalized patients data can be also observed in Piemonte,
and the ability to foresee peaks of COVID-19 patients admitted in hospital was
restored (Figure 15 in the bottom).
5.5 TPR index trend vs control measures
The last point of this discussion concerns the relationship between the TPR
index and the Italian minister’s of health three-tiered system issued at the be-
ginning of November 2020 to combat the spread of COVID-19. In this system
regions are classified in three zones with increasing restrictions on the basis of
ISS reports [13, 14, 15].
• Yellow zone: moderate risk, bars and restaurants must stop service at
18:00; cinemas, theatres, swimming pools and gyms are closed. People
are not allowed to be out of their home from 22:00 to 05:00, except for
work or health reasons.
• Orange zone: medium-high risk, most non-essential shops can stay open,
while bars and restaurants must close, apart from for takeaway services;
people can move freely within their cities, but cannot travel elsewhere.
• Red zone: high-contagion-risk, non-essential shops and markets are closed
and residents are only allowed to leave their homes for work, health reasons
or emergencies.
Additionally, region Veneto has decreed strengthened yellow and orange
zones with closure of shopping malls at weekends, and banning the movements





















































Piemonte: TPR index using antigen tests
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Figure 15: PIEMONTE region TPR index trend: in the top the broken series;
in the middle the series removing antigen tests; in the bottom the series using
antigen tests.
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Figures 11, 14, 12, and 15 illustrate the relationship between the course of
TPR index and the measures adopted for Italian regions. Several considerations
can be done analysing these figures.
The first observation that can be made concerns the possibility of anticipat-
ing pandemic control interventions, if the continuous and significant increasing
of TPR index had been observed at the beginning of October 2020. This effect
was clear for all the 4 analysed regions.
Another, issue concern yellow zones, it appears that they have not a sig-
nificant impact on reducing the TPR index, while both orange and red zones
effectively do it.
Finally, for all the considered regions the effect of the Christmas partial
lock down has led to a lowering of the TPR index in the successive weeks. We
define this phenomena breakwater effect, as in the case of sea waves a sequence
of bulwarks has a significant cost effective impact on the reduction of effects of
stormy seas, a sequence of short lock down (3/4 days) seems to be able to reduce
the impact of the COVID-19 on the population. Moreover, we noticed that the
reduction of the TPR index was greater if the higher the number of tests done
in the same period. Veneto did the higher number of tests, Piemonte, Toscana
and Alto Adige followed in order.
6 Standardizing antigen tests data.
The simple TPR estimation method we exploited works fine, even if the infor-
mation we have is limited to the number of antigen tests done in a given day
only.
Anyway, the precision of this index could be improved, if more structured
information will be made available, eventually including data on vaccinate indi-
viduals. Indeed, considering that COVID-19 diagnosis using antigen tests only
are also possible (see the report [16]), additional information is needed to repre-
sent this eventuality. More precisely, the data that should be collected for each
day are the following:
• dayA: the number of antigent tests;
• dayAp: the number of positive antigen tests;
• dayAd : the number of COVID-19 diagnosis based only on antigen tests.
• dayV : the number of vaccined persons.
The new factor ΦV will be:
ΦV =
N − I − dayV − dayTµ − dayAµ + dayRµ + Pr
N − I − dayV
(12)
where Pr is the number of repeated tests, computed as follows:
Pr = dayAp− dayAd (13)
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if the dayAp data are not made available, they can still be computed using the
approach presented above (Equation 7). The new TPR index ΘVµ which includes
antigen tests and vaccinate individuals is defined by the following formula:
ΘVµ = Θ
A
µ ∗ ΦV (14)
which would allow to estimate the TPR in a context in which the number of
susceptible continuously decreases.
Although, the data on antigen tests made recently available in the Protezione
Civile site are slightly different, they can be easily used to compute the proposed
index. They include, the number of molecular tests, the number of antigen tests,
the number of positive molecular tests, and the number of COVID-19 diagnosis
based only on antigen tests dayAd. Thus dayAp, the number of positive antigen
tests is not provided, while it can still be estimated using the proposed method.
7 Conclusion
We have shown that a well defined daily test positivity rate is a powerful index
that can be used to control the evolution of the COVID-19 pandemic. Indeed, in
some situations it would be possible to forecast peaks of hospitalized people and
the associated variations in percentage. Antigen tests data have to be considered
for making TPR reliable. The behaviour of the proposed index is studied using
the data of Italian regions, considering both the first and the second phase of the
pandemic. We extended the Italian Protezione Civile dataset [17] with antigen
tests for Alto Adige, Toscana Veneto and Piemonte. This extended dataset
allowed us to study the impact of antigen tests in epidemic control strategies
and the effects of screening campaigns on the population.
From this study two promising response strategies emerge for COVID-19:
adopting early interventions if the TPR index starts to grow significantly for
more then 10-15 days; a breakwater cost effective strategy done of short lock
down (3/4 days a week) repeated for two or three weeks, combined with an
extensive testing campaign.
To conclude, a extended TPR index including a more complete formalization
of antigen tests and the number of vaccinate people is proposed.
Future work will concern the definition of rules of thumb to indicate measures
to adopt if certain TPR patterns are discovered. Although, the data on antigen
tests are now available in the Protezione Civile web site [17], a further effort
should be done to reconstruct past time series for all the Italian regions. This
would allow scientists to study in a more accurate way the evolution of the
TPR index combined with the adopted measures and the effects of the proposed
strategies and screening policies on the pandemic course.
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